SMARCB1 and chronic myelogenous leukemia, BCR-ABL1 positive: INI1 is now recognized as a tumor suppressor, due to its mutation in tumors including choroid plexus carcinoma, medulloblastoma, primitive neuroectodermal tumor, and chronic myeloid leukemia.